Right ventricular dysfunction and remodeling in diabetic cardiomyopathy.

The increasing prevalence of diabetic cardiomyopathy (DCM) is an important threat to health worldwide. While left ventricular (LV) dysfunction in DCM is well recognized, the accurate detection, diagnosis, and treatment of changes in right ventricular (RV) structure and function have not been well characterized. The pathophysiology of RV dysfunction in DCM may share features with LV diastolic and systolic dysfunction, including pathways related to insulin resistance and oxidant injury, although the RV has a unique cellular origin and composition and unique biomechanical properties and is coupled to the lower-impedance pulmonary vascular bed. In this review, we discuss potential mechanisms responsible for RV dysfunction in DCM and review the imaging approaches useful for early detection, protection, and intervention strategies. Additional data are required from animal models and clinical trials to better identify the onset and features of altered RV and pulmonary vascular structure and function during the onset and progression of DCM and to determine the efficacy of early detection and treatment of RV dysfunction on clinical symptoms and outcomes.

[1]  E. Bedrick,et al.  Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension. , 2018, The American journal of medicine.

[2]  R. Gropler,et al.  Contemporary Advances in Myocardial Metabolic Imaging and Their Impact on Clinical Care: a Focus on Positron Emission Tomography (PET) , 2018, Current Cardiovascular Imaging Reports.

[3]  Sanjiv J. Shah,et al.  Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology , 2018, European journal of heart failure.

[4]  J. Newman,et al.  Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension , 2017, Pulmonary circulation.

[5]  Inas I Eweda Hypertension and Diabetes Mellitus: How Do They Affect the Right Ventricular Functions Individually and Together? , 2017, Journal of cardiovascular echography.

[6]  K. Otsu,et al.  Inflammation and metabolic cardiomyopathy. , 2017, Cardiovascular research.

[7]  E. Picano,et al.  Dual‐Imaging Stress Echocardiography for Prognostic Assessment of High‐Risk Asymptomatic Patients with Diabetes Mellitus , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[8]  Shixue Liu,et al.  Role of microRNAs in the pathogenesis of diabetic cardiomyopathy. , 2017, Biomedical reports.

[9]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. , 2011, Diabetes research and clinical practice.

[10]  J. Sowers,et al.  Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease , 2017, Diabetologia.

[11]  K. Aonuma,et al.  Myocardial dysfunction identified by three-dimensional speckle tracking echocardiography in type 2 diabetes patients relates to complications of microangiopathy. , 2016, Journal of cardiology.

[12]  R. Gil,et al.  The role of invasive diagnostics and its impact on the treatment of dilated cardiomyopathy: A systematic review. , 2016, Advances in medical sciences.

[13]  Xiaohong Wang,et al.  Hsp20-Mediated Activation of Exosome Biogenesis in Cardiomyocytes Improves Cardiac Function and Angiogenesis in Diabetic Mice , 2016, Diabetes.

[14]  S. Lavandero,et al.  New Molecular Insights of Insulin in Diabetic Cardiomyopathy , 2016, Front. Physiol..

[15]  J. Sowers,et al.  Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy , 2016, Nature Reviews Endocrinology.

[16]  D. Leung,et al.  Impact of Improved Glycemic Control on Cardiac Function in Type 2 Diabetes Mellitus , 2016, Circulation. Cardiovascular imaging.

[17]  M. Gladwin,et al.  SIRT3–AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction , 2016, Circulation.

[18]  Jie-ning Zhu,et al.  Left ventricular deformation associated with cardiomyocyte Ca2+ transients delay in early stage of low-dose of STZ and high-fat diet induced type 2 diabetic rats , 2016, BMC Cardiovascular Disorders.

[19]  M. Kurt,et al.  Assessment of subclinical left ventricular dysfunction in patients with psoriasis by speckle tracking echocardiography: A Speckle Tracking Study , 2016, International journal of dermatology.

[20]  A. Heusch,et al.  Subclinical Alterations of Cardiac Mechanics Present Early in the Course of Pediatric Type 1 Diabetes Mellitus: A Prospective Blinded Speckle Tracking Stress Echocardiography Study , 2015, Journal of diabetes research.

[21]  Ricardo Aurino Pinho,et al.  The role of continuous versus fractionated physical training on muscle oxidative stress parameters and calcium-handling proteins in aged rats , 2016, Aging Clinical and Experimental Research.

[22]  W. Paulus,et al.  Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes. , 2015, European heart journal.

[23]  N. Weissmann,et al.  Pressure Overload Creates Right Ventricular Diastolic Dysfunction in a Mouse Model: Assessment by Echocardiography. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[24]  E. Aasum,et al.  How Exercise May Amend Metabolic Disturbances in Diabetic Cardiomyopathy , 2015, Antioxidants & redox signaling.

[25]  S. Archer,et al.  Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension: Part I Metabolic Plasticity and Mitochondrial Dynamics in the Pulmonary Circulation and Right Ventricle in Pulmonary Arterial Hypertension , 2015, Circulation.

[26]  T. Marwick,et al.  Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus , 2015, Heart.

[27]  C. Lam Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction , 2015, Diabetes & vascular disease research.

[28]  R. Dweik,et al.  Impact of Diabetes in Patients with Pulmonary Hypertension , 2015, Pulmonary circulation.

[29]  G. Kocabay,et al.  Right heart mechanics in untreated normotensive patients with prediabetes and type 2 diabetes mellitus: a two- and three-dimensional echocardiographic study. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[30]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[31]  E. Brittain,et al.  Impact of Diabetes on Survival and Right Ventricular Compensation in Pulmonary Arterial Hypertension , 2014, Pulmonary circulation.

[32]  P. Croisille,et al.  Longitudinal myocardial strain alteration is associated with left ventricular remodeling in asymptomatic patients with type 2 diabetes mellitus. , 2014, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[33]  J. Egido,et al.  Activation of Toll-Like Receptors and Inflammasome Complexes in the Diabetic Cardiomyopathy-Associated Inflammation , 2014, International journal of endocrinology.

[34]  Wei Zhang,et al.  Diastolic function of the right ventricle is impaired in experimental type 2 diabetic rat models. , 2014, Turkish journal of medical sciences.

[35]  T. Hey,et al.  Left atrial volume index: relation to long-term clinical outcome in type 2 diabetes. , 2013, Journal of the American College of Cardiology.

[36]  Hai-tao Zhu,et al.  Protein kinase RNA- like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)- mediated endoplasmic reticulum stress- induced apoptosis in diabetic cardiomyopathy , 2013, Cardiovascular Diabetology.

[37]  K. Takatsu,et al.  Activation and Regulation of the Pattern Recognition Receptors in Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance , 2013, Nutrients.

[38]  V. Demarco,et al.  Molecular and metabolic mechanisms of cardiac dysfunction in diabetes. , 2013, Life sciences.

[39]  Jeroen J. Bax,et al.  Right Ventricular Involvement in Diabetic Cardiomyopathy , 2013, Diabetes Care.

[40]  S. Erzurum,et al.  Novel Therapeutic Approaches to Preserve the Right Ventricle , 2013, Current Heart Failure Reports.

[41]  P. Steendijk,et al.  Left ventricular dysfunction induced by nonsevere idiopathic pulmonary arterial hypertension: a pressure-volume relationship study. , 2012, American journal of respiratory and critical care medicine.

[42]  F. Reis,et al.  The role of inflammation in diabetic cardiomyopathy , 2012 .

[43]  O. Vittos,et al.  Biomarkers and their involvement in the early diagnosis of right ventricular dysfunction in type 2 Diabetes Mellitus , 2012, Journal of medicine and life.

[44]  N. Maredia,et al.  3D Echo systematically underestimates right ventricular volumes compared to cardiovascular magnetic resonance in adult congenital heart disease patients with moderate or severe RV dilatation , 2011, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[45]  K. Griendling,et al.  Vascular smooth muscle insulin resistance, but not hypertrophic signaling, is independent of angiotensin II-induced IRS-1 phosphorylation by JNK. , 2011, American journal of physiology. Cell physiology.

[46]  P. Croisille,et al.  Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? , 2011, Journal of the American Society of Echocardiography.

[47]  C. Byrne,et al.  Acute Hypoglycemia Decreases Myocardial Blood Flow Reserve in Patients With Type 1 Diabetes Mellitus and in Healthy Humans , 2011, Circulation.

[48]  W. Haverkamp,et al.  Right ventricular myocardial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[49]  A. Rosengren,et al.  Glycaemic control and incidence of heart failure in 20 985 patients with type 1 diabetes: an observational study , 2011, The Lancet.

[50]  M. Zavolan,et al.  MicroRNAs 103 and 107 regulate insulin sensitivity , 2011, Nature.

[51]  T. Rice,et al.  Unrecognized glucose intolerance is common in pulmonary arterial hypertension. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[52]  E. Herzog,et al.  Right ventricular dysfunction is a strong predictor of developing atrial fibrillation in acutely decompensated heart failure patients, ACAP-HF data analysis. , 2010, Journal of cardiac failure.

[53]  M. Lubberink,et al.  investigationDiabetic cardiomyopathy in Zucker diabetic fatty rats : the forgotten right ventricle , 2015 .

[54]  Ana Ludke,et al.  Oxidative stress: a key contributor to diabetic cardiomyopathy. , 2010, Canadian journal of physiology and pharmacology.

[55]  E. Abel,et al.  Diabetic cardiomyopathy, causes and effects , 2010, Reviews in Endocrine and Metabolic Disorders.

[56]  C. Scott,et al.  The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study. , 2010, Journal of the American College of Cardiology.

[57]  C. Warnes,et al.  Adult congenital heart disease importance of the right ventricle. , 2009, Journal of the American College of Cardiology.

[58]  Jeroen J. Bax,et al.  Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. , 2009, Journal of the American College of Cardiology.

[59]  Godfrey L. Smith,et al.  Interval Training Normalizes Cardiomyocyte Function, Diastolic Ca2+ Control, and SR Ca2+ Release Synchronicity in a Mouse Model of Diabetic Cardiomyopathy , 2009, Circulation research.

[60]  H. Krum,et al.  Inhibition of Protein Kinase C–β by Ruboxistaurin Preserves Cardiac Function and Reduces Extracellular Matrix Production in Diabetic Cardiomyopathy , 2009, Circulation. Heart failure.

[61]  J. Flores-Hernández,et al.  Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[62]  Ze-Zhou Song,et al.  Early diastolic impairment of diabetic heart: the significance of right ventricle. , 2008, International journal of cardiology.

[63]  S. Hunt,et al.  Right Ventricular Function in Cardiovascular Disease, Part II: Pathophysiology, Clinical Importance, and Management of Right Ventricular Failure , 2008, Circulation.

[64]  P. Sipkema,et al.  Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity , 2008, Cell and Tissue Research.

[65]  S. Mittal Right ventricular functions in patients with type 2 diabetes below 50 years. , 2007, The Journal of the Association of Physicians of India.

[66]  W. Kosmala,et al.  Subclinical right ventricular dysfunction in diabetes mellitus—an ultrasonic strain/strain rate study , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[67]  P. Humpert,et al.  Non-invasive diagnostic imaging techniques as a window into the diabetic heart: a review of experimental and clinical data. , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[68]  M. Movahed,et al.  Presence of biventricular dysfunction in patients with type II diabetes mellitus. , 2007, Congestive heart failure.

[69]  C. Papadopoulos,et al.  Early diastolic impairment of diabetic heart: the significance of right ventricle. , 2007, International journal of cardiology.

[70]  R. Gropler,et al.  Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. , 2006, European heart journal.

[71]  Qianwen Wang,et al.  Causes and characteristics of diabetic cardiomyopathy. , 2006, The review of diabetic studies : RDS.

[72]  T. Marwick,et al.  Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging , 2006, Heart.

[73]  A. Grandi,et al.  Effect of glycemic control on left ventricular diastolic function in type 1 diabetes mellitus. , 2006, The American journal of cardiology.

[74]  B. Culver,et al.  Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice. , 2006, The Journal of endocrinology.

[75]  P. D. de Tombe,et al.  Depressed cardiac myofilament function in human diabetes mellitus. , 2005, American journal of physiology. Heart and circulatory physiology.

[76]  M. Movahed,et al.  The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus. , 2005, Chest.

[77]  T. Marwick,et al.  Screening for heart disease in diabetic subjects. , 2005, American heart journal.

[78]  S. Nunoda,et al.  Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitus , 1985, Heart and Vessels.

[79]  P. Colonna,et al.  Right ventricular dysfunction in asymptomatic diabetic patients. , 2004, Diabetes care.

[80]  G. Lip,et al.  Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart. , 2004, Archives of internal medicine.

[81]  K. Gemitzis,et al.  Evidence of Left Ventricular Dysfunction in Asymptomatic Elderly Patients with Non-insulin-dependent Diabetes Mellitus , 2004, Angiology.

[82]  G. King,et al.  Microvascular complications of diabetes. , 2004, Endocrinology and metabolism clinics of North America.

[83]  Kieran Clarke,et al.  Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes , 2003, Circulation.

[84]  N. Lamblin,et al.  Influence of diabetes mellitus on heart failure risk and outcome , 2003, Cardiovascular diabetology.

[85]  J. Wahren,et al.  C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. , 2002, Diabetes.

[86]  G. King,et al.  Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. , 2002, Diabetes.

[87]  L. Cai,et al.  Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. , 2002, Diabetes.

[88]  M. Brownlee Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[89]  E. Frohlich,et al.  Diabetes, Hypertension, and Cardiovascular Disease: An Update , 2001, Hypertension.

[90]  J Meluzín,et al.  Pulsed Doppler tissue imaging of the velocity of tricuspid annular systolic motion; a new, rapid, and non-invasive method of evaluating right ventricular systolic function. , 2001, European heart journal.

[91]  L. Tavazzi,et al.  Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. , 2001, Journal of the American College of Cardiology.

[92]  P. Poirier,et al.  Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. , 2001, Diabetes care.

[93]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[94]  J. Sowers,et al.  Diabetes and cardiovascular disease. , 1999, Diabetes care.

[95]  G. King,et al.  Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[96]  A. Weyman,et al.  Echocardiographic Assessment of Right Ventricular Volume and Function , 1997, Echocardiography.

[97]  V. Palmieri,et al.  Early abnormalities of cardiac function in non-insulin-dependent diabetes mellitus and impaired glucose tolerance. , 1995, The American journal of cardiology.

[98]  W L Maughan,et al.  Contribution of External Forces to Left Ventricular Diastolic Pressure: Implications for the Clinical Use of the Starling Law , 1995, Annals of Internal Medicine.

[99]  D. Levy,et al.  Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). , 1991, The American journal of cardiology.

[100]  M. Roberts,et al.  Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. , 1988, Journal of the American College of Cardiology.

[101]  W. Kannel,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[102]  S. Ahmed,et al.  Evidence for cardiomyopathy in familial diabetes mellitus. , 1977, The Journal of clinical investigation.

[103]  A. Grishman,et al.  New type of cardiomyopathy associated with diabetic glomerulosclerosis. , 1972, The American journal of cardiology.

[104]  K. Lundbæk Diabetic angiopathy: a specific vascular disease. , 1954 .